Albidus Tablets
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
MFDS item code 201902581 · Approved 2019.04.24
This product's status changed to Expired on 2024.04.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of ulcers (gastric, duodenal, etc.) and acid-related disorders (gastritis, etc.); prevention of Mendelson syndrome
This medication is used for diseases such as gastric and duodenal ulcers, gastritis, and Zollinger-Ellison syndrome. It is also helpful in the treatment of gastroesophageal reflux disease and is administered to prevent Mendelson's syndrome prior to surgery. It is utilized for the treatment of gastric and duodenal ulcers caused by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). It is effective in alleviating and treating the symptoms of various gastrointestinal-related diseases.
Usually administer 2 tablets per dose orally twice daily, regardless of meals, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets once daily before bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and before bedtime. The same dose applies to ulcers caused by nonsteroidal anti-inflammatory drugs and to combination therapy for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use generally heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose 3 times daily and increase the dose if needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.
This medication should not be used in patients undergoing dialysis or those with reduced kidney function. It should also not be given to individuals who are allergic to this drug or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants and newborns, and those on a dietary regimen restricting potassium intake. Caution is advised in individuals with liver dysfunction, a history of drug allergies, elderly patients, those with a previous history of kidney problems, and patients taking NSAIDs. Especially since it can mask symptoms of gastric cancer, patients with gastric ulcers or middle-aged and older individuals who newly experience dyspeptic symptoms should confirm malignancy before use. Patients with Helicobacter pylori infection associated with gastric or duodenal ulcers require eradication therapy. Critical patients in intensive care or those with hypophosphatemia should also be cautious. This medication can rarely cause severe allergic reactions such as anaphylactic shock; if any unusual symptoms occur during administration, discontinue the medication immediately and seek appropriate treatment. Hypersensitivity reactions such as skin rash, urticaria, angioedema, fever, bronchospasm, and hypotension may also occur, and usage should be stopped if these symptoms appear. Various side effects have been reported, including reduced blood cell counts, liver function abnormalities, arrhythmias, gastrointestinal symptoms, dizziness, drowsiness, and mental confusion, so inform medical personnel if symptoms occur. This medication should not be used for prolonged periods without effect, and other medications should be considered. Regular blood tests and liver and kidney function tests should be performed. Elderly patients or those with chronic conditions may have an increased risk of pneumonia. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so inform medical personnel of any medications being taken, especially when used with certain antibiotics or anticoagulants. Pregnant or breastfeeding women should not use this medication, and safety in children has not been established, so administration is not recommended. Because it can affect test results, caution is needed during urine protein tests, and appropriate emergency measures such as vomiting or gastric lavage may be necessary in case of overdose. Lastly, this medication can reduce gastric acid secretion, promoting bacterial growth in the stomach, and long-term use may lead to side effects related to ocular melanin, necessitating ophthalmic examination.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container to prevent air from entering, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. This will maintain the effectiveness of the medication and ensure safe usage.
White round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.